RIMITIVE neuroectodermal tumors of the CNS are malignant neoplasms with distinct histopathological and immunohistochemical characteristics.
Abbreviations used in this paper: CNS = central nervous system; CT = computerized tomography; FDG = [ P from C-3 to C-5. The dura mater was opened in the midline. The cervical cord was found to be distinctly displaced to the right and posteriorly by a mass in the left anterior subarachnoid space. The arachnoid mater appeared normal and was opened. The cervical cord was observed to be enlarged from C-3 to C-5. A well-defined, yellowish, fleshy tumor was noted in the left anterior subarachnoid space. During the biopsy procedure, the tumor was found to be soft, easily suctioned, and moderately vascular. At C-3 and C-4 the left nerve roots were enmeshed in the mass. Because the left hemicord and nerve roots were infiltrated by the tumor, a partial excision was performed. Multiple biopsy specimens were obtained. After the excision, the spinal cord was lax and pulsating with a free egress of cerebrospinal fluid. A lax duraplasty was performed; the patient tolerated the surgery well.
Postoperative Course. Postoperatively, the patient's limb strength improved to Grade 3 in her right limbs and left lower limb, and to Grade 2 in her left upper limb, according to the manual muscle test. Her breathing also improved, but her constipation and urinary retention persisted.
Pathological Examination. Histological examination of biopsy specimens revealed the tumor to be densely cellular, essentially consisting of small-to intermediate-sized cells with hyperchromatic, round-to-oval, mitotically active nuclei. The tumor cells were arranged in nodules of varying sizes with intervening sheets of cellular tumor tissue. The nodules had a relatively differentiated appearance; they were less cellular and had slightly larger, more uniform nuclei with relatively open chromatin, a more prominent fibrillary network with Homer-Wright rosettes, and small neuropil islands. In contrast, the internodular tumor tissue was more densely cellular with overlapping, more hyperchromatic nuclei. This tissue contained less intercellular fibrillary matrix and fewer rosettes ( Fig. 2A) . A separate fragment containing many ganglion cells was also seen.
Immunohistochemical analysis showed the nodules to be rich in synaptophysin, particularly in the rosettes and neuropil islands, and poor in reticulin content. In contrast, the internodular tumor tissue showed decreased synaptophysin and increased reticulin content ( Fig. 2 B and C) . The MIB-1 labeling index was more than 90% in hot spots of the internodular tumor and between 10 and 20% within the nodules (Fig. 2D ). Immunostaining for p53 and WT1 was negative. Stains for thyroid transcription factor-1 and MIC2 were also negative. Additional immunostains for MYCC, MYCN, Trk-c, and ␤-catenin were negative (courtesy of Dr. Shirsat from the Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India). The overall morphological characteristics and immunophenotype were those of a PNET with nodular growth and neuronal differentiation. The tumor had a striking resemblance to desmoplastic medulloblastoma.
Further Evaluation and Treatment. Because primary PNET of the spinal cord is a very rare disease and because of the patient's age, after the histopathological diagnosis of spinal cord PNET was established, additional imaging studies were performed to rule out the possibility of the spinal cord lesion representing metastasis from a primary tumor elsewhere in the body or having itself metastasized. A whole-body FDG-PET-CT scan showed intensely increased uptake (standardized uptake value 9.7) in the spinal canal from C2-3 to C4-5. Corresponding plain CT images obtained using the same scanner showed an ill-defined residual soft-tissue mass in this region (Fig. 3) . Postlaminectomy changes were also seen from C-3 to C-5. The remaining scans were otherwise unremarkable, ruling out any other focus of neoplastic disease. A brain MR image was also nondiagnostic (Fig. 4) . The diagnosis of primary intramedullary PNET of the spinal cord was thus established. The patient was given craniospinal radiotherapy with a radiation boost to the tumor bed. Since she received radiotherapy, the patient has remained neurologically stable with no further improvement. As we write this paper, adjuvant chemotherapy is being considered.
Discussion
Management of PNETs of the brain consists of surgical excision followed by craniospinal radiotherapy with a radiation boost to the primary tumor with or without chemotherapy. A PNET originating from the spinal cord, however, is a rare occurrence. We have been able to identify only 26 cases of intraspinal PNET in the literature. 2,5,8,9,11-13, 15,17,20-24 The tumors were classified as intramedullary, intradural-extramedullary, or epidural, with the majority arising from the cauda equina. Intradural-extramedullary and epidural PNETs can be considered peripheral tumors. Compared with brain PNETs, which occur primarily in pediatric patients, intraspinal PNETs tend to occur in an older age group. (The median age of patients in the reported cases is 28 years, and five of the patients were older than 45 years of age at diagnosis.)
Six cases of central primary PNET arising from the spinal cord have previously been reported. Four of these were exclusively intramedullary and two had an extramedullary component as well. 1, 4, 6, 10, 14, 16 In all six cases with intramedullary involvement, the tumors occurred in the thoracic or lumbar cord (Table 1) . To the best of our knowledge, this present case represents the first well-documented cervical intramedullary PNET.
Central nervous system PNETs are believed to arise from malignant transformation of primitive neuroepithelial cells in subependymal zones. 18 Subependymal zones of the spinal cord should also harbor these primitive cells, and why it is so rare for these cells to undergo malignant transformation is still an enigma.
Our patient was 54 years of age at diagnosis, and her case is only the second case of intramedullary PNET reported in the literature as having been diagnosed in a middle-aged or elderly patient. The patient described by Mawrin and colleagues 14 was 69 years of age at diagnosis. The other reported cases of intramedullary PNETs involve children and young adults.
The imaging presentation of spinal cord PNET does not seem to be distinct from that of spinal cord astrocytoma or ependymoma, and the diagnosis is usually based on the histopathological findings. A diagnosis of spinal cord PNET should be established on histopathological exami- nation and confirmed by immunohistochemical analysis, as in this case. Moreover, due to the extreme rarity of spinal cord PNET, the possibility of metastasis from a central PNET such as medulloblastoma or a peripheral PNET should be ruled out by performing imaging studies and, in the latter instance, by demonstrating absence of MIC-2 and thyroid transcription factor-1 expression, as in this case. The current case was unique in that the tumor was found to have a nodular growth pattern on histopathological examination, with neuronal differentiation and striking resemblance to desmoplastic medulloblastoma. 7 Because desmoplastic histological characteristics have recently been demonstrated to predict better survival independently in cases of medulloblastoma, 19 the histological attributes observed here are of particular interest and importance. The lesion in this case did not display immunopositivity for the putative prognostic markers MYCC, MYCN (unfavorable), ␤-catenin, or Trk-c (favorable). Molecular analysis was precluded by the unavailability of frozen tissue and limited laboratory facilities.
After establishing a diagnosis of spinal cord PNET, it is imperative to rule out the possibility of the lesion being metastatic in origin as well as the possibility of its having metastasized from a primary PNET elsewhere. Magnetic resonance imaging of the whole brain and spine should be performed to exclude leptomeningeal or drop metastases. A complete metastatic evaluation should be done. We performed FDG-PET scanning to rule out any active disease elsewhere in the body. (With the exception of brain lesions, FDG-PET is quite sensitive in the detection of occult malignant disease.)
The prognosis for patients with intramedullary PNETs of the spinal cord seems to be very poor. Of the six patients described in previous articles, one was alive 15 months after diagnosis, and the other five died between 3 and 29 months postdiagnosis. This could be due to the incomplete evaluation of the disease in the craniospinal axis and elsewhere or inadequate treatment.
The management of spinal cord PNET is a particularly challenging clinical issue. Complete excision is usually not possible, as the tumor infiltrates the spinal cord and/or nerve roots. Craniospinal radiotherapy should therefore be employed with the addition of a radiation boost to the primary tumor. The role of chemotherapy is unclear, and its use in cases of spinal cord PNET has been inconsistent. 1, 4 However, extrapolating from the experience with patients suffering from medulloblastomas or supratentorial PNETs, chemotherapy should be strongly considered for patients with spinal cord PNETs who have gross residual disease or microscopic or macroscopic metastases. Intense physiotherapy and rehabilitation must also be part of the comprehensive management to facilitate neurological recovery. 
